George K. Gessner, President Mr. Gessner has spent over 40 years in the pharmaceutical industry primarily in sales, product management and new product development of both branded and generic pharmaceutical products and devices.
Mr. Gessner is founder and president of RRI Group, which provides regulatory and project management consulting services to pharmaceutical companies that need assistance in the development of total product projects. Mr. Gessner formed RRI in 2005 after retiring as Vice President of Business Development for SFBC/Pharmanet, a leading CRO in the pharmaceutical industry.
Prior to SFBC, Mr. Gessner had his own product development consulting company and associated CRO, which was merged into SFBC in 2000. Mr. Gessner also held senior positions with Johnson & Johnson, Merck Inc. and William H. Rorer. Mr. Gessner was responsible for the new product development of several marketed pharmaceutical and device products while at J&J.
Mr. Gessner holds a B.S. in Chemistry from Muhlenberg College and a B.A. and M.B.A. in Marketing from Temple University.
Zaidoon A. al-Zubaidy, Vice President of Operations
Zaidoon Al-Zubaidy is currently the Vice President, Operations for RRI Group providing overall direction and
guidance to the operational activities of the organization with the objective of maximizing growth and profitability as
well as day-to-day leadership and management of all company operations functions.
Prior to RRI Group, Zaidoon was the Senior Director, Clinical Research and development at Actavis Inc.,
responsible for developing and implementing a biopharmaceutics/ pharmacokinetics program to support an R&D
team devoted to the development of new generic drug products. Prior to Actavis Inc., Zaidoon served as the
Director of R&D and Clinical Development at Interpharm Inc. He was responsible for advanced research towards
the development of generic pharmaceutical products and for the biopharmaceutic assessment of pharmaceutical
products to determine their readiness for bioequivalence studies.
Mr. Al-Zubaidy has managed the overall clinical program for Sandoz Canada, and has global experience with clinical
research organizations (CROs) from India, South Africa and North America.
Prior to working for generic pharmaceutical companies, Zaidoon spent three years as a pharmacokinetic manager
at a global CRO, responsible for the interpretation of pharmacokinetic data & compilation of pharmacokinetic related
reports.
Zaidoon Al-Zubaidy served as the Chair of the Bioequivalence Committee for the Canadian Generic Pharmaceutical
Association, representing the Canadian generic industry's concerns to Health Canada, and working cooperatively
with Health Canada.
Zaidoon earned a Masters degree from the University of Alberta, Canada (Physiology).
Product Marketing Opportunities
